Physician profile
Christopher Michael White
NPI 1770840043
$22,572.91
in general payments reported to CMS, 2019-2025
20 companies · $9,461 in 2025
The $9,461 reported for 2025 was more than what 95% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,195 · 2020: $3,077 · 2021: $103 · 2022: $330 · 2023: $81.41 · 2024: $325 · 2025: $9,461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,250 · Travel and Lodging: $1,433 · Food and Beverage: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,250.00 |
| Travel and Lodging | $1,433.17 |
| Food and Beverage | $184.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $21,665.23 | 2019-2025 | |
| Ethicon US, LLC | $136.28 | 2019-2022 | |
| Heron Therapeutics, INC. | $125.18 | 2022-2024 | Zynrelef |
| Medtronic Vascular, INC. | $115.20 | 2019 | |
| Medtronic, INC. | $81.32 | 2022-2023 | Emprint |
| Helsinn Therapeutics (U.S.), INC. | $68.84 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $52.06 | 2021 | |
| Smith+Nephew, INC. | $44.39 | 2020-2022 | |
| Kerecis Limited | $35.83 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Organogenesis INC. | $30.90 | 2024 | Puraply Am |
| Acell, INC. | $30.00 | 2019 | |
| Innocoll Pharmaceuticals Limited | $29.13 | 2022 | |
| Baxter Healthcare | $26.38 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $26.12 | 2019 | |
| Rti Surgical, INC | $24.86 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $24.42 | 2022 | |
| Abbvie INC. | $18.31 | 2021 | |
| Novo Nordisk INC | $14.21 | 2019 | |
| Shire North American Group INC | $13.09 | 2019 | |
| Osiris Therapeutics INC. | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.